VTGN's financial position deteriorated significantly with operating losses nearly doubling to $56M while cash reserves declined 44% to $67.1M, raising concerns about runway and operational sustainability.
The company is burning through cash at an accelerated rate with operating cash flow worsening 63% to -$42.1M, while simultaneously increasing R&D spending by 97% to $39.4M for their late-stage pherine pipeline. With cash declining from $119M to $67M and current liabilities increasing 146%, investors should closely monitor the company's funding runway and potential need for additional capital raises.
VTGN's financial metrics show severe deterioration across all key areas, with net losses expanding 75% to -$51.4M driven primarily by a 97% increase in R&D expenses to $39.4M, while revenue turned negative at -$227K. The balance sheet weakened substantially as cash reserves fell 44% to $67.1M and current liabilities surged 146% to $12.6M, though total debt was largely eliminated. Combined with operating cash flow deteriorating 63% to -$42.1M, the overall picture signals significant cash burn acceleration that could pressure the company's funding runway despite their late-stage clinical progress.
Interest expense surged 300% — significant debt increase or rising rates materially impacting earnings.
Revenue declined 226.1% — significant demand weakness or market share loss warrants investigation.
Current liabilities surged 146.2% — significant near-term obligations; verify ability to meet short-term debt.
Debt reduced 97.4% — deleveraging strengthens balance sheet and reduces financial risk.
R&D investment increased 96.7% — signals commitment to future product development, though near-term margin impact.
Net income declined 75.1% — review whether driven by operations, interest costs, or non-recurring items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Operating cash flow fell 63.1% — earnings quality concerns; investigate working capital changes and non-cash items.
Liabilities grew 48.9% — significant increase in debt or obligations, assess impact on financial flexibility.
Cash declined 43.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →